US Contraceptive Market

U.S. Contraceptive Market Size, Share, Growth Analysis, By Product(Pills, Intrauterine Devices (IUD) (Hormonal IUD, Nonhormonal IUD ), Condoms (Male Condoms), By Age-group(15-44 years, above 44 years), By End-User(Households, clinics, Hospitals), By Region - Industry Forecast 2024-2031


Report ID: SQMIC35I2325 | Region: Country | Published Date: February, 2024
Pages: 157 |Tables: 95 |Figures: 78

U.S. Contraceptive Market Insights

US Contraceptive Market size was valued at USD 7.88 billion in 2019 and is poised to grow from USD 8.3 billion in 2023 to USD 12.15 billion by 2031, growing at a CAGR of 5.16% in the forecast period (2024-2031).

Contraception, or birth control, is the use of medications, devices, or surgery to prevent pregnancy. Some of them are reversible, while others are irreversible. Some varieties can also aid in the prevention of sexually transmitted infections (STDs). Increased usage of contemporary contraceptives and increased knowledge of sexual health and family planning among teenagers and the young population are significant factors driving market expansion in the United States. Furthermore, government initiatives have increased access to contraceptives, which aid in the prevention of unplanned births in teens. According to the Guttmacher Institute, 60% of women of reproductive age in the United States utilize contraception. Among married women, the use of hormonal contraceptives other than the birth control pill has grown dramatically.

The increased availability of contraception in the United States has benefited various elements of society, including women's education, professional possibilities, and poverty. Access to contemporary contraceptive techniques has substantially increased job options for women and allowed them to earn pay on par with males. It has also decreased the number of women living in poverty as a result of unwanted pregnancies and the high expenditures of childrearing. The legalisation of family planning in the majority of states has lowered the economic burden for the next generation, since the number of persons living in poverty as adults have decreased significantly.

US Contraceptive Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

U.S. Contraceptive Market Segmental Analysis

US Contraceptive Market is segmented based on the product, age-group, and end-user. Based on product, the market is segmented into Pills, Intrauterine Devices (IUD) (Hormonal IUD and Nonhormonal IUD ), Condoms (Male Condoms and Female Condoms), Vaginal Ring, Subdermal Implants, Injectable, and Others. Based on age-group, the market is segmented into 15-44 years and above 44 years. Based on end-user, the market is categorized into households, clinics, and hospitals.

US Contraceptive Market Analysis by Product

The contraceptive market in the United States has been divided into tablets, intrauterine devices (IUD), condoms, vaginal rings, subdermal implants, injectables, and others. Oral contraceptive pills accounted for the biggest market in 2021 due to a huge variety of products produced by numerous market participants, a high success rate (99.0% when used precisely), and the ease of use of oral pills for contraception. These medications are only accessible with a gynecologist's prescription and can be used for a variety of diseases, including dysmenorrhea, amenorrhea, hypermenorrhea, endometriosis, and others. The safety and convenience of administration of tablets have contributed to their appeal among young women in the United States.

The popularity of male condoms is high among young individuals due to easy availability, economic pricing, and added advantage of protection against STDs. Moreover, the availability of a vast range of variants in various sizes, flavors, textures, and thicknesses helps enhance sexual experience of users.

Furthermore, in the recent decade, there has been a dramatic improvement in the acceptance of long-acting reversible contraceptives. During the projected period, intrauterine devices, injectables, and vaginal rings are predicted to rise at a steady rate. The market is driven by cost-effectiveness and extended product life cycles. The introduction of new products, as well as the convenience of use of vaginal rings, are projected to boost demand for such birth control techniques.

US Contraceptive Market Analysis by Age-Group

Over the course of a year, sexually active couples who do not use any form of contraception have an 85% chance of becoming pregnant. The average number of children considered ideal by adults in the United States is 2.7. A sexually active woman must use contraception for approximately three decades to achieve this family size. Contraception use among sexually active women who were not seeking pregnancy was lowest among 15-24-year-olds (83%) and highest among 25-34-year-olds (91%). More than 99% of sexually active women in the United States aged 15 to 44 have used at least one contraceptive method.

To get detailed analysis on other segments, Request For Free Sample Report

U.S. Contraceptive Market Regional Insights

During the projection period, development, approval, and commercialization of novel, more effective, and long-acting reversible contraceptive techniques are likely to boost the market growth. Agile Therapeutics, for example, created Twirla, a hormonal patch that will be available in the United States in the fourth quarter of 2020. The availability of generic and low-cost medications and technologies has increased the need for contraception among teens. Furthermore, nonhormonal contraceptives are becoming increasingly popular in the United States since they reduce the danger of undesirable consequences linked with hormonal imbalance in the body. In 29 states, insurers must provide comprehensive coverage for FDA-approved contraceptive methods for women. Over-the-counter contraceptives are covered in 12 states; however, insurers may require a prescription from the beneficiary. In 20 states and the District of Columbia, insurers are required to cover a large number of contraceptives at once.

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

U.S. Contraceptive Market Dynamics

US Contraceptive Market Driver

  • The introduction of more effective male contraception products is expected to boost contraceptive sales. Female contraceptives are currently the market leaders, but male contraceptives will see increased demand due to the increased use of male condoms.

Condom use is increasing due to its dual role in birth control and the prevention of sexually transmitted diseases (STD). Furthermore, it has little to no side effects on the body.

Unmet needs among women of reproductive age in developing countries include limited access to contraception, a limited choice of methods, social and religious issues, poor quality of available services, and gender-based barriers. All of these unmet needs can increase the likelihood of unintended pregnancy. As a result, manufacturers are aiming to expand their products and services across developing economies to improve sales

US Contraceptive Market Restraint

  • Birth control pills and devices, particularly progestin-only pills, can cause spotting or bleeding between periods, as well as sore breasts, nausea, and headaches. In rare cases, blood clots in the legs, heart attacks and strokes, liver disorders, and gallbladder disease are all serious side effects. During the forecast period, these contraceptive-related side effects will limit sales. Misinformation, a lack of social acceptance, and exaggerated concerns about the safety of contraceptive methods are also significant barriers to contraceptive use.

Furthermore, oral contraceptives increase the risk of heart disease. IUDs are effective contraception; however, in some high-risk individuals, they increase the risk of infection. Although barrier contraception is less effective than other forms of contraception, it does protect against sexually transmitted infections such as HIV. Because of differences in the prevalence of the disorders involved, the value of non-contraceptive benefits and contraceptive risks varies by country

Request Free Customization of this report to help us to meet your business objectives.

U.S. Contraceptive Market Competitive Landscape

Attributed to the existence of multiple enterprises, the global market is very competitive. Most businesses are pursuing strategic initiatives, such as R&D spending, in order to produce innovative goods and acquire a competitive advantage over rivals. High expenditures by well-known corporations in the commercialization of effective and long-term reversible contraception have raised public awareness of these products.

US Contraceptive Market Top Player's Company Profiles

  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group plc
  • CooperSurgical, Inc.
  • Medicines360
  • Agile Therapeutics, Inc.
  • Afaxys, Inc.
  • HRA Pharma
  • TherapeuticsMD, Inc.
  • Apothecus Pharmaceutical Corporation
  • Mayer Laboratories, Inc.
  • The Female Health Company
  • Lumara Health Inc.
  • Veru Inc.
  • The Population Council, Inc.

US Contraceptive Market Recent Developments

  • On October 2022, to consider the application submitted by HRA Pharma, a Paris-based pharmaceutical company owned by the Perrigo Company, to make its progesterone-only mini-pill available in the U.S. without a prescription.
  • In July 2022, Evofem Biosciences, Inc. announced the creation of a new educational birth control chart that provides high-level information about the various options available to women in the United States.

U.S. Contraceptive Key Market Trends

  • Current oral contraceptive products also include novel progestins, which have changed the scope of benefits and side effects. Approximately half of all pregnancies in the United States are unintended, and more than one in every five pregnancies in the United States ends in abortion. A study of over 10,000 women who sought abortions discovered that 46% did not use a contraceptive method during the month they conceived. Extended-cycle COCs, drospirenone-containing products, chewable contraceptive pills, and emergency contraceptive options are among the recent contraceptive advances. Sterilization is the most popular method of contraception in the United States. Many women who choose sterilization before the age of 30 later express regret and report doing so because they were unaware of equally effective reversible alternatives. In the United States, combination oral contraceptives (COCs) are the most commonly used reversible form of birth control.

U.S. Contraceptive Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our U.S. Contraceptive Market, The United States has the highest rate of adolescent pregnancy. Government activities such as promoting sex education and providing access to contraception are projected to increase the country's use of different birth control techniques. Because of their ease of use and accessibility, pills held the biggest market share in 2021. Because of the prevalence of generic medications, the country's contraceptive pill industry is very competitive. Sub dermal implants are expected to increase rapidly in the US contraceptive industry in the coming years. The subdermal implants market is largely consolidated, with only a few companies present. During the early phases of the COVID-19 epidemic, the shutdown of production operations in China and Southeast Asian nations resulted in a lack of items such as condoms and implants. Generic rivalry, industry consolidation, competing combination products, new information from clinical trials of marketed drugs, and patents issued to rivals' new goods, among other factors, have an impact on market participants' operations.

Report Metric Details
Market size value in 2023 USD 7.88 billion
Market size value in 2031 USD 12.15 billion
Growth Rate 5.16%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Pills, Intrauterine Devices (IUD) (Hormonal IUD, Nonhormonal IUD ), Condoms (Male Condoms, Female Condoms), Vaginal Ring, Subdermal Implants, Injectable, Others
  • Age-group
    • 15-44 years, above 44 years
  • End-User
    • Households, clinics, Hospitals
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Bayer AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group plc
  • CooperSurgical, Inc.
  • Medicines360
  • Agile Therapeutics, Inc.
  • Afaxys, Inc.
  • HRA Pharma
  • TherapeuticsMD, Inc.
  • Apothecus Pharmaceutical Corporation
  • Mayer Laboratories, Inc.
  • The Female Health Company
  • Lumara Health Inc.
  • Veru Inc.
  • The Population Council, Inc.

US Contraceptive Market Recent Developments

  • On October 2022, to consider the application submitted by HRA Pharma, a Paris-based pharmaceutical company owned by the Perrigo Company, to make its progesterone-only mini-pill available in the U.S. without a prescription.
  • In July 2022, Evofem Biosciences, Inc. announced the creation of a new educational birth control chart that provides high-level information about the various options available to women in the United States.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on U.S. Contraceptive Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on U.S. Contraceptive Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the U.S. Contraceptive Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the U.S. Contraceptive Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the U.S. Contraceptive Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the U.S. Contraceptive Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

US Contraceptive Market size was valued at USD 7.88 billion in 2019 and is poised to grow from USD 8.3 billion in 2023 to USD 12.15 billion by 2031, growing at a CAGR of 5.16% in the forecast period (2024-2031).

Attributed to the existence of multiple enterprises, the market is very competitive. Most businesses are pursuing strategic initiatives, such as R&D spending, in order to produce innovative goods and acquire a competitive advantage over rivals. High expenditures by well-known corporations in the commercialization of effective and long-term reversible contraception have raised public awareness of these products. 'Bayer AG', 'Pfizer Inc.', 'Merck & Co., Inc.', 'Allergan plc', 'Teva Pharmaceutical Industries Ltd.', 'Mylan N.V.', 'Church & Dwight Co., Inc.', 'Reckitt Benckiser Group plc', 'CooperSurgical, Inc.', 'Medicines360', 'Agile Therapeutics, Inc.', 'Afaxys, Inc.', 'HRA Pharma', 'TherapeuticsMD, Inc.', 'Apothecus Pharmaceutical Corporation', 'Mayer Laboratories, Inc.', 'The Female Health Company', 'Lumara Health Inc.', 'Veru Inc.', 'The Population Council, Inc.', 'On October 2022, to consider the application submitted by HRA Pharma, a Paris-based pharmaceutical company owned by the Perrigo Company, to make its progesterone-only mini-pill available in the U.S. without a prescription.', 'In July 2022, Evofem Biosciences, Inc. announced the creation of a new educational birth control chart that provides high-level information about the various options available to women in the United States.'

The introduction of more effective male contraception products is expected to boost contraceptive sales. Female contraceptives are currently the market leaders, but male contraceptives will see increased demand due to the increased use of male condoms.

Current oral contraceptive products also include novel progestins, which have changed the scope of benefits and side effects. Approximately half of all pregnancies in the United States are unintended, and more than one in every five pregnancies in the United States ends in abortion. A study of over 10,000 women who sought abortions discovered that 46% did not use a contraceptive method during the month they conceived. Extended-cycle COCs, drospirenone-containing products, chewable contraceptive pills, and emergency contraceptive options are among the recent contraceptive advances. Sterilization is the most popular method of contraception in the United States. Many women who choose sterilization before the age of 30 later express regret and report doing so because they were unaware of equally effective reversible alternatives. In the United States, combination oral contraceptives (COCs) are the most commonly used reversible form of birth control.

During the projection period, development, approval, and commercialization of novel, more effective, and long-acting reversible contraceptive techniques are likely to boost the market growth. Agile Therapeutics, for example, created Twirla, a hormonal patch that will be available in the United States in the fourth quarter of 2020. The availability of generic and low-cost medications and technologies has increased the need for contraception among teens. Furthermore, nonhormonal contraceptives are becoming increasingly popular in the United States since they reduce the danger of undesirable consequences linked with hormonal imbalance in the body. In 29 states, insurers must provide comprehensive coverage for FDA-approved contraceptive methods for women. Over-the-counter contraceptives are covered in 12 states; however, insurers may require a prescription from the beneficiary. In 20 states and the District of Columbia, insurers are required to cover a large number of contraceptives at once.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

US Contraceptive Market

Product ID: SQMIC35I2325

$3,500
BUY NOW GET FREE SAMPLE